The ESMO Sarcoma and Rare Cancers Congress 2026 will once again serve as a premier forum for sharing groundbreaking research, novel treatment strategies, and fostering collaborations to drive progress in this crucial area of oncology.

The scientific and educational programme will explore the latest advancements in diagnosis, treatment, biology, and molecular classification of rare solid tumours, ensuring a comprehensive update on the evolving landscape of these complex diseases.

Attendees can engage in Abstract-related sessions, educational lectures, Multidisciplinary Tumour Boards, Special Sessions, Guidelines discussions, and dedicated Young Oncologists sessions, all designed to enhance knowledge and foster interactive discussions.

Whether you are a clinician, researcher, healthcare professional, industry expert, or patient advocate, this congress offers a unique opportunity to connect, learn, and contribute to the future of sarcoma and rare cancer care.